RenovoRx Maximum Drawdown
| RNXT Stock | | | USD 0.85 -0.01 -0.58% |
Maximum Drawdown (or MDD) is another indicator of risk. It is the reduction in asset value after a series of losing trades. This is normally calculated by getting the difference between a relative peaks in equity capital minus a relative trough. Below is RenovoRx's current Maximum Drawdown with peer comparisons and related risk metrics.
Current Maximum Drawdown Value
RenovoRx registers a Maximum Drawdown of 21.08, reflecting a moderate peak-to-trough loss. This places RenovoRx's drawdown exposure within the typical range for Biotechnology.
Maximum Drawdown | = | MAX(HIGH - LOW) |
| = | 21.08 | |
| MAX | = | Maximum notation for the range of returns on RenovoRx |
Maximum Drawdown Peers Comparison
The peer group averages 35.62 for Maximum Drawdown, with RenovoRx at 21.08 falling below that level. Readings span 10.06 (PolyPid) to 69.07 (Reviva Pharmaceuticals Holdings). RenovoRx's shallower drawdown relative to peers indicates more contained historical downside.
Maximum Drawdown Relative To Other Indicators
The chart below plots Maximum Drawdown against Maximum Drawdown for RenovoRx and its peers. Each point represents one equity — position along the horizontal axis shows Maximum Drawdown while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Comparing Maximum Drawdown (
21.08 ) to Maximum Drawdown (
21.08 ) for RenovoRx yields a
1.00 multiple. The two measures are closely aligned in magnitude for RenovoRx.
Methodology, Assumptions & Data Sources
RenovoRx's Maximum Drawdown currently stands at 21.08. The Maximum Drawdown for RenovoRx is produced by transforming raw price history into a standardized measure according to the indicator's defined methodology. Price data is sourced from standardized end-of-day feeds across supported exchanges, normalized for corporate actions. RenovoRx operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. The calculation assumes continuous price data across the selected period. All readings are presented as reference data.
Other Technical Indicators